Results 21 to 30 of about 182,098 (265)

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

Hepatology, EarlyView., 2022
Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres, Cristina Ortiz, Nadine Bachtler, Wenyi Gu, Leon D. Grünewald, Nico Kraus, Robert Schierwagen, Christoph Hieber, Caroline Meier, Olaf Tyc, Maximilian Joseph Brol, Frank Erhard Uschner, Bart Nijmeijer, Christoph Welsch, Marie‐Luise Berres, Carmen Garcia‐Ruiz, Jose Carlos Fernandez‐Checa, Christian Trautwein, Thomas J. Vogl, Stefan Zeuzem, Jonel Trebicka, Sabine Klein   +21 more
wiley   +1 more source

Laparoscopic portosystemic shunt attenuation in two cats

Journal of Feline Medicine and Surgery Open Reports, 2022
Case series summary Gradual attenuation of an extrahepatic portosystemic shunt using cellophane banding was achieved with a laparoscopic technique in two cats.
Francesca Izzo, Edoardo Poggi, Francisco J Pérez Duarte, Filippo Cinti   +3 more
doaj   +1 more source

Progress of pulmonary hypertension and high manganese levels through congenital portosystemic shunt closure

Clinical Case Reports, 2022
A 6‐year‐old girl with congenital portosystemic shunt presented with abnormal manganese levels and improving pulmonary hypertension even 1 year after shunt vascular ligation. As the progress after portal vein blood flow recovery varies among individuals,
Toshihiko Kakiuchi, Yuta Baba, Nobuya Minematsu, Hirohito Doi, Takashi Kumamoto   +4 more
doaj   +1 more source

The incidence of portal vein thrombosis at liver transplantation [PDF]

, 1992
The incidence of portal vein thrombosis was examined in 885 patients who received orthotopic liver transplantations for various end‐stage liver diseases between 1989 and 1990. The thrombosis was classified into four grades.
Iwatsuki, S, Nonami, T, Starzl, TE, Yokoyama, I   +3 more
core   +1 more source

Extrahepatic portosystemic shunt

Radiopaedia.org, 2019
V. Shah, James Mirow
openaire   +2 more sources

A basic understanding of congenital extrahepatic portosystemic shunt: incidence, mechanism, complications, diagnosis, and treatment.

Intractable & Rare Diseases Research, 2020
Extrahepatic portosystemic shunt belongs to a family of rare vascular abnormalities. The clinical importance and manifestations of this vascular abnormality range from asymptomatic cases to liver or metabolic dysfunctions of various degrees.
Haowen Tang, Peipei Song, Zhiqiang Wang, B. Han, XiangFei Meng, Yingwei Pan, Xuan Meng, W. Duan   +7 more
semanticscholar   +1 more source

Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting

Radiology Case Reports, 2021
Nodular regenerative hyperplasia (NRH) of the liver may lead to noncirrhotic portal hypertension with subsequent development of portosystemic shunts. While extrahepatic and macrovascular shunts are readily visualized with imaging or endoscopy, there is ...
Cynthia De la Garza-Ramos, MD, Mohamed S. Muneer, MD, Jason T. Lewis, MD, Denise M. Harnois, DO, C. Burcin Taner, MD, Gregory T. Frey, MD, Barry Rosser, MD, Beau B. Toskich, MD   +7 more
doaj   +1 more source

Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts [PDF]

, 2002
Background. We have recently shown that the transjugular intrahepatic portosystemic shunt (TIPS) is more effective than paracentesis in the treatment of cirrhotic patients with severe ascites and can prolong survival in selected patients.
Bilzer, M., Gerbes, Alexander L., Gülberg, Veit, Liss, I., Reiser, Maximilian F., Waggershauser, T.   +5 more
core   +1 more source

Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications

United European Gastroenterology journal, 2020
Background Treatment of refractory ascites in liver cirrhosis is challenging. Transjugular intrahepatic portosystemic shunt and alfapump® have been proposed for the management, but few data comparing both exist. Aims The aim of this study was to evaluate
Valerie Will, S. Rodrigues, G. Stirnimann, A. Gottardi, J. Bosch, A. Berzigotti   +5 more
semanticscholar   +1 more source

Transhepatic embolization of a congenital intrahepatic portosystemic shunt for the treatment of hepatic encephalopathy in a noncirrhotic patient using Amplatzer vascular plug device

Radiology Case Reports, 2017
A 73-year-old male with no history of liver disease was hospitalized for weakness, confusion, ataxia, and new onset hepatic encephalopathy with hyperammonemia.
Rachel Ann Brader, BS, Kyung Rae Kim, MD
doaj   +1 more source